Publications by authors named "Angelo Pontes Freitas Campos"
Mult Scler Relat Disord
September 2020
Article Synopsis
- Alemtuzumab (ALZ) is a monoclonal antibody used to treat recurrent remittent multiple sclerosis (RRMS) by depleting CD52-expressing T and B cells, while preserving stem and innate immune cells.
- Long-term studies have linked ALZ to autoimmune diseases like thrombocytopenic purpura and thyroiditis, with two new reported cases of autoimmune hemophilia A (AHA) following ALZ infusion in Brazil.
- AHA is a serious condition that can be life-threatening if not treated quickly, highlighting the need for specific coagulation tests and monitoring after ALZ treatment.
